The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2027 from USD 1.7 billion in 2020, at a CAGR of 16.2%
.
The diabetes care devices (or) equipment market is made up of entities (organisations, sole traders, and partnerships) that sell diabetes care devices and related services. Diabetes care devices are used to monitor and control blood glucose levels in diabetic patients. This industry includes companies that make blood glucose test strips, continuous glucose monitoring devices, and blood glucose metres for checking blood glucose levels, as well as insulin pens, syringes, pumps, and injectors for injecting insulin.
Competitive Landscape: The key players of Global Diabetes Care Devices Market are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, and Dickinson and Company (US).
.
The diabetes care devices (or) equipment market is made up of entities (organisations, sole traders, and partnerships) that sell diabetes care devices and related services. Diabetes care devices are used to monitor and control blood glucose levels in diabetic patients. This industry includes companies that make blood glucose test strips, continuous glucose monitoring devices, and blood glucose metres for checking blood glucose levels, as well as insulin pens, syringes, pumps, and injectors for injecting insulin.
Drivers:
The growing diabetes-affected patient pool and obesity-affected population, combined with lifestyle issues and rapid international research collaboration across the globe, are expected to accelerate market growth during the forecast period. Furthermore, there is a surge in demand for faster and safer diabetes diagnosis and treatment, and the government is taking initiatives to provide better health services, which will pave the way for market growth.Restraints:
The high cost of diabetes care and the adverse effects associated with some diabetes care devices are expected to slow the market's growth rate.Impact of Covid-19
The COVID-19 pandemic significantly slowed the growth of the diabetic care device market. COVID-19 infected patients' blood glucose levels increased. The stress of infection, as well as the use of steroids for COVID-19 treatment, caused blood glucose levels to rise, resulting in an increase in the number of patients. The market's major players were undoubtedly given opportunities as a result of this.Market Segmentation
- Segmentation By Product: Global Diabetes Care Devices Market is classified on the basis of Product into Blood glucose monitoring devices and Insulin Pens, Syringes, Pumps And Injectors.
- Segmentation By End-User: Global Diabetes Care Devices Market is classified on the basis of End-User into Hospitals & specialty clinics and Self & home care.
- Segmentation By Region: Global Diabetes Care Devices Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape: The key players of Global Diabetes Care Devices Market are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, and Dickinson and Company (US).
Industrial Development
- Abbott (US) received US FDA approval in February 2020 for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.
- In April 2020, Ypsomed (Switzerland) announced a collaboration with DexCom, Inc. (US) to integrate mylife YpsoPump data with DexCom's G6 CGM sensors to create a hybrid closed-loop system.
- In January 2020, LifeScan (US) announced a partnership agreement with DKSH to provide marketing, sales, regulatory services, distribution, and logistics for LifeScan product sales in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
Market Taxonomy
By Product
- Blood glucose monitoring devices
- Insulin Pens, Syringes, Pumps And Injectors
By End User
- Hospitals & specialty clinics
- Self & home care
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Diabetes Care Devices Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Frequently Asked Questions about the Global Diabetes Care Devices Market
What is the estimated value of the Global Diabetes Care Devices Market?
What is the growth rate of the Global Diabetes Care Devices Market?
What is the forecasted size of the Global Diabetes Care Devices Market?
Who are the key companies in the Global Diabetes Care Devices Market?
Report Attribute | Details |
---|---|
Published | February 2022 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 24.3 Billion |
Forecasted Market Value ( USD | $ 37 Billion |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 13 |
Table of Contents
1 Introduction
2 Research Methodology
4 Global Diabetes Care Devices Market
12 Middle East & Africa Diabetes Care Devices Market Analysis and Forecast (2021-2027)
13 Competitive Analysis
Companies Mentioned
- Medtronic plc (Ireland)
- B. Braun (Germany)
- DexCom Inc. (US)
- Abbott (US)
- F. Hoffman-La Roche Ltd. (Switzerland)
- Ascensia Diabetes Care Holdings AS (Switzerland)
- LifeScan (US)
- AgaMatrix Holdings LLC (US)
- Acon Laboratories Inc. (US)
- ARKRAY USA Inc. (US)
- Novo Nordisk A/S (Denmark)
- Becton
- Dickinson and Company (US).